ArticleThe AAPS journal2017

Immune Suppression During Preclinical Drug Development Mitigates Immunogenicity-Mediated Impact on Therapeutic Exposure.

Jonathan Herskovitz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.